Sarepta Therapeutics
Together, We Soar
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
The Opportunity
Your Opportunity Title
-
Video with Hiring Manager
-
Overview
The Overview of the position will be tailored to the information the Hiring Manager shares with us during Needs Analysis Profile meeting.
-
Responsibilities
We will customize the Responsibilities section based on the information we receive from the hiring manager during the Needs Analysis Profile meeting.
-
Qualifications
We will customize the Qualifications section based on the information we receive from the hiring manager during the Needs Analysis Profile meeting.
-
Sarepta Therapeutics Announces That U.S. FDA has Accepted for Filing and Granted Priority Review for the Biologics License Application for SRP-9001, Sarepta’s Gene Therapy for the Treatment of Ambulant Individuals with Duchenne Muscular Dystrophy
Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate